How genetically engineered mouse tumor models provide insights into human cancers

Katerina Politi1, William Pao

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY, USA. katerina.politi@yale.edu

Insights

Genetically engineered mouse models (GEMMs) advance cancer research by modeling human cancers. These sophisticated tools are crucial for understanding drug resistance, metastasis, and early detection, aiding cancer diagnosis and treatment.

Area of Science:

  • Oncology
  • Genetics
  • Translational Medicine

Background:

  • Genetically engineered mouse models (GEMMs) have been instrumental in cancer research for nearly three decades.
  • Early models demonstrated oncogene-induced transformation of mouse cells in vivo, establishing a new field of study.

Purpose of the Study:

  • To review the significant contributions of GEMMs to the diagnosis and treatment of human cancers.
  • To highlight the clinical relevance of GEMMs through representative examples, rather than an exhaustive list.

Main Methods:

  • Focus on genetically engineered mouse models (GEMMs) of human cancer.
  • Review representative examples of GEMM applications in cancer research.
  • Exclude chemically induced or spontaneous tumor models from the discussion.

Main Results:

  • GEMMs are sophisticated tools for studying diverse cancer biology aspects.
  • These models are vital for investigating drug sensitivity and resistance mechanisms.
  • GEMMs aid in understanding oncogene cooperation, early cancer detection, and metastasis.

Conclusions:

  • GEMMs have profoundly impacted cancer biology, diagnosis, and treatment strategies.
  • The ongoing development of advanced GEMMs continues to drive progress in oncology.
  • GEMMs provide critical insights for improving patient outcomes in human cancer care.